Highest-materiality recent filing
Acadia subsidiary faces $105M jury verdict in retaliatory termination suit
San Diego jury awarded $35M compensatory and $70M punitive damages on May 12, 2026.
Acadia Healthcare annual meeting: directors elected, incentive plan and say-on-pay approved
Three Class III directors elected with >73M votes each: Cancelmi, Fucci, Harris.
Acadia Healthcare Q1 revenue up 7.6% to $828.8M; raises FY2026 guidance
Revenue $828.8M (+7.6% YoY); same-facility revenue +7.3%.
Todd Young resigns as CFO effective April 30, 2026; to join private equity-backed animal health company.
Acadia Healthcare appoints Dan Cancelmi to board; Wade Miquelon to retire at 2026 annual meeting
Daniel Cancelmi, former Tenet Healthcare EVP & CFO, appointed to Acadia's Board effective March 12, 2026.
Acadia Healthcare Q4 net loss $13.02/sh on $996M goodwill impairment; appoints new CEO
Q4 revenue $821.5M (+6.1% YoY); net loss $13.02/diluted share from $996.2M goodwill impairment.
CEO Christopher H. Hunter resigned and left Board effective Jan 20, 2026; no successor named.
Acadia Healthcare appoints former CEO Debra Osteen as CEO; Chris Hunter departs
Debra Osteen appointed CEO and Class I director effective January 20, 2026; previously served as CEO from 2018-2022.
Acadia Healthcare reaffirms 2025 revenue $3.28-3.30B, adj. EBITDA $601-611M, adj. EPS $1.94-2.04
Reaffirmed 2025 guidance at J.P. Morgan Healthcare Conference: revenue $3.28B-$3.30B.
Acadia Healthcare lowers 2025 guidance after actuarial review shows $49M PLGL expense increase
Adjusted EBITDA guidance reduced to $601-611M from $650-660M; adjusted EPS to $1.94-2.04 from $2.35-2.45.
Acadia Healthcare settles securities class action for $179M; no admission of liability
Settlement of $179M resolves St. Clair County ER Sys. v. Acadia Healthcare case with no admission of liability.
Acadia Q3 revenue $851.6M (+4.4% YoY), net income falls; cuts full-year guidance; COO resigns
Q3 net income $36.2M ($0.40 diluted) vs $0.74 prior year; adjusted EPS $0.72 vs $0.91.
Acadia Healthcare appoints Todd Young as CFO effective Oct 27, 2025
Todd Young, former Elanco Animal Health CFO, appointed as Acadia Healthcare CFO effective Oct 27, 2025.
Acadia Healthcare 2026 capex to drop at least $300M; Q3 same-facility patient days up 1.3%
Total 2026 capex expected to decline at least $300M from 2025 guidance of $600-$650M.
Acadia Q2 revenue $869M (+9.2%), adjusted EPS $0.83; CFO Dixon resigns, Sides interim
Q2 revenue $869.2M (+9.2% YoY); same-facility revenue +9.5% with 7.5% higher rev/patient day.
Four Class II directors elected: Bernhard 77.5M for, Grieco 71.9M, Kelly 75.6M, Waud 63.6M (broker non-votes 2.2M).
Acadia Healthcare Q1 revenue $770.5M, net income $8.4M, affirms FY2025 guidance
Revenue $770.5M, up 0.3% YoY from $768.1M; same-facility revenue +2.1%, patient days +2.2%.
Acadia Healthcare prices $550M 7.375% senior notes due 2033 to repay revolver
Issued $550M aggregate principal of 7.375% Senior Notes due March 15, 2033.
Acadia Healthcare enters $1.65B senior secured credit facility, extends maturities to 2030
New $1B revolver and $650M term loan, both due Feb 28, 2030; replaces $600M revolver and term loan due Mar 2026.
Acadia Healthcare Q4 2024 revenue $774.2M (+4.2%); adj. EPS $0.64; announces $300M buyback
Q4 net income $32.6M ($0.35 diluted EPS); adjusted income $59.2M ($0.64 diluted EPS).
Acadia Healthcare Q4 same-facility patient days +3.2% YoY, in-line with prior guidance
Same-facility patient days for Q4 2024 grew 3.2% year-over-year.
Acadia Q3 revenue $815.6M (+8.7%), adj. EPS $0.91; margins expand
Revenue $815.6M, up 8.7% YoY; adjusted EBITDA $194.3M, up 10.5% YoY (excl. provider relief funds).
Acadia Healthcare receives federal subpoenas over admissions, billing practices
Voluntary request from US Attorney's Office (SDNY) and grand jury subpoena from Western District of Missouri.
Acadia Healthcare Q2 revenue up 8.8% to $796M; adj. EPS $0.91 provides updated 2024 guidance
Revenue $796.0M (+8.8% YoY); same-facility revenue +8.3% (patient days +2.6%, revenue/patient day +5.6%).
Acadia Healthcare appoints Dr. Nasser Khan as COO; board declassified
Dr. Nasser Khan appointed COO effective June 30, 2024; base salary $515,000, target bonus 85%.
Acadia Healthcare Q1 revenue up 9.1% to $768.1M, adjusted EBITDA up 14.9%, affirms FY2024 guidance
Revenue $768.1M (+9.1% YoY); same-facility revenue +9.2%; net income $76.4M ($0.83 diluted EPS).
Appointment of Dr. Nasser Khan as Chief Operating Officer On May 23, 2024, Acadia Healthcare Company, Inc. (the “Company”) announced the appointment of Dr. Nasser Khan as the Chief Operating Officer of the Company, effective June 30, 2024.
Max materiality 0.85 · Median 0.70 · Most common event earnings